comparemela.com

Mirvetuximab soravtansine demonstrated efficacy and tolerability in patients with platinum resistant ovarian cancer, according to phase 3 clinical data presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

Related Keywords

Phoenix ,Arizona ,United States ,Ursula Matulonis ,Ovarian Cancer Research Alliance ,Rivkin Foundation ,Alkermes ,Harvard Medical School ,Novartis ,Astrazeneca ,Clearity Foundation ,Dana Farber Cancer Institute ,Gynecologic Oncology Annual Meeting ,Blueprint Medicines ,Brock Wilson Family Chair ,Harvard Medical ,Published March ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.